Cargando…
Neutralising antibody response in domestic cats immunised with a commercial feline immunodeficiency virus (FIV) vaccine
Across human and veterinary medicine, vaccines against only two retroviral infections have been brought to market successfully, the vaccines against feline leukaemia virus (FeLV) and feline immunodeficiency virus (FIV). FeLV vaccines have been a global success story, reducing virus prevalence in cou...
Autores principales: | Bęczkowski, Paweł M., Harris, Matthew, Techakriengkrai, Navapon, Beatty, Julia A., Willett, Brian J., Hosie, Margaret J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4327927/ https://www.ncbi.nlm.nih.gov/pubmed/25613718 http://dx.doi.org/10.1016/j.vaccine.2015.01.028 |
Ejemplares similares
-
Emergence of CD134 cysteine-rich domain 2 (CRD2)-independent strains of feline immunodeficiency virus (FIV) is associated with disease progression in naturally infected cats
por: Bęczkowski, Paweł M, et al.
Publicado: (2014) -
Contrasting clinical outcomes in two cohorts of cats naturally infected with feline immunodeficiency virus (FIV)
por: Bęczkowski, Paweł M., et al.
Publicado: (2015) -
Feline immunodeficiency virus (FIV) env recombinants are common in natural infections
por: Bęczkowski, Paweł M, et al.
Publicado: (2014) -
The Comparative Value of Feline Virology Research: Can Findings from the Feline Lentiviral Vaccine Be Translated to Humans?
por: Hosie, Margaret J., et al.
Publicado: (2017) -
The virus–receptor interaction in the replication of feline immunodeficiency virus (FIV)()
por: Willett, Brian J, et al.
Publicado: (2013)